A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home
NCT06639958 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2025-08-29
Summary
This clinical trial tests different programs to help patients with acute lymphoblastic leukemia (ALL) remember to take their medications during maintenance therapy at home. One problem with ALL maintenance treatment is remembering to take medicines at home like patients are supposed to. In maintenance, a medicine called 6-mercaptopurine or "6MP" is taken by mouth every day at home. In this study, 6MP prescriptions are filled into a special medication bottle called MEMS® which is fitted with a special cap called TrackCap™ that electronically records when the medication bottle is opened. Researchers are trying a new program to help patients be better at taking their 6MP like they're supposed to. This new program may help patients to remember to take their 6MP medication.
Conditions
- Acute Lymphoblastic Leukemia
- Childhood Acute Lymphoblastic Leukemia
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo blood sample collection
- BEHAVIORAL
-
Compliance Monitoring
Receive DST
- BEHAVIORAL
-
Compliance Monitoring
Healthcare provider reviews DST response rates with the patient and any challenges they are having with 6MP adherence every 4 weeks at clinic visits
- OTHER
-
Health Promotion and Education
Receive customized printed medication schedules
- OTHER
-
Informational Intervention
Receive Patient Supply Kit
- OTHER
-
Media Intervention
View MIPE program videos
- OTHER
-
Media Intervention
Review booster MIPE videos
- OTHER
-
Medical Device Usage and Evaluation
Use MEMS® with TrackCap™
- DRUG
-
Mercaptopurine
Given PO
- OTHER
-
Questionnaire Administration
Ancillary studies
- BEHAVIORAL
-
Telephone-Based Intervention
Receive automated customized electronic reminders via smartphone
- BEHAVIORAL
-
Telephone-Based Intervention
Receive additional automated reminders
- BEHAVIORAL
-
Telephone-Based Intervention
Manually activate daily smartphone reminders with successive alerts (using the "snooze" function)
- BEHAVIORAL
-
Telephone-Based Intervention
Receive electronic reminders with successive alerts (using the "snooze" function)
- BEHAVIORAL
-
Training and Education
Undergo training for prompting and supervising 6MP
Sponsors & Collaborators
-
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Smita Bhatia · Children's Oncology Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 10 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-04
- Primary Completion
- 2027-03-03
- Completion
- 2027-03-03
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
NCT00136084 ·Status: COMPLETED ·Phase: PHASE3
-
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
NCT06446661 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00558519 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
NCT00002766 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00005596 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00343369 ·Status: UNKNOWN ·Phase: NA
-
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
NCT00075725 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
NCT01920737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study
NCT05595135 ·Status: WITHDRAWN ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
NCT00003700 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
NCT00136435 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
NCT00005945 ·Status: COMPLETED ·Phase: PHASE3
-
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
NCT03022747 ·Status: UNKNOWN ·Phase: PHASE2
-
Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
NCT02126553 ·Status: COMPLETED ·Phase: PHASE2
-
ALL Adult Consortium Trial: Adult ALL Trial
NCT00476190 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00103285 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00002700 ·Status: COMPLETED ·Phase: PHASE3
-
Home Away From Home - Medical Outcomes
NCT02774850 ·Status: COMPLETED
-
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
NCT05811845 ·Status: RECRUITING
-
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT02666950 ·Status: COMPLETED ·Phase: PHASE2
-
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
NCT03204916 ·Status: COMPLETED
-
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
NCT01156883 ·Status: COMPLETED ·Phase: NA
-
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
NCT02535806 ·Status: TERMINATED ·Phase: PHASE2